C4 Therapeutics, Inc. (CCCC)
3.14
+0.29
(+10.18%)
USD |
NASDAQ |
Oct 09, 14:33
C4 Therapeutics Market Cap : 385.92M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 08, 2026 | 350.28M |
| October 07, 2026 | 346.59M |
| October 06, 2026 | 353.97M |
| October 05, 2026 | 367.49M |
| October 02, 2026 | 362.57M |
| October 01, 2026 | 385.92M |
| September 30, 2026 | 409.28M |
| September 29, 2026 | 384.70M |
| September 28, 2026 | 382.85M |
| September 25, 2026 | 366.26M |
| September 24, 2026 | 372.40M |
| September 23, 2026 | 378.55M |
| September 22, 2026 | 406.82M |
| September 21, 2026 | 405.59M |
| September 18, 2026 | 416.65M |
| September 17, 2026 | 419.72M |
| September 16, 2026 | 424.02M |
| September 15, 2026 | 421.57M |
| September 14, 2026 | 421.57M |
| September 11, 2026 | 431.40M |
| September 10, 2026 | 417.88M |
| September 09, 2026 | 422.80M |
| September 08, 2026 | 436.32M |
| September 04, 2026 | 462.13M |
| September 03, 2026 | 459.67M |
| Date | Value |
|---|---|
| September 02, 2026 | 465.81M |
| September 01, 2026 | 475.65M |
| August 31, 2026 | 455.98M |
| August 28, 2026 | 473.19M |
| August 27, 2026 | 503.91M |
| August 26, 2026 | 521.12M |
| August 25, 2026 | 516.20M |
| August 24, 2026 | 503.91M |
| August 21, 2026 | 491.62M |
| August 20, 2026 | 495.31M |
| August 19, 2026 | 517.43M |
| August 18, 2026 | 513.75M |
| August 17, 2026 | 524.19M |
| August 14, 2026 | 521.12M |
| August 13, 2026 | 501.46M |
| August 12, 2026 | 479.33M |
| August 11, 2026 | 475.65M |
| August 10, 2026 | 444.92M |
| August 07, 2026 | 458.44M |
| August 06, 2026 | 447.38M |
| August 05, 2026 | 376.61M |
| August 04, 2026 | 375.57M |
| August 03, 2026 | 364.13M |
| July 31, 2026 | 362.05M |
| July 30, 2026 | 380.77M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Intellia Therapeutics, Inc. | 1.834B |
| Arrowhead Pharmaceuticals, Inc. | 8.827B |
| Oncolytics Biotech, Inc. | 69.42M |
| Sangamo Therapeutics, Inc. | 58.04M |
| Sarepta Therapeutics, Inc. | 1.895B |
Market Cap Related Metrics
| PS Ratio | 9.995 |
| Price to Book Value | 1.561 |
| Price | 3.14 |
| Earnings Yield | -31.81% |